Medline Inc - Class A

Research Medline Inc - Class A (MDLN) on Bullrun: valuation model: 1.7% overvalued, market cap USD 33.49B, P/E 33.1. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerMDLN
ExchangeNASDAQ
CountryUnited States
SectorHealthcare
IndustryMedical Instruments & Supplies
CurrencyUSD
Valuation signal1.7% overvalued
Market capUSD 33.49B
P/E33.1
Financial periodFY2025
RevenueUSD 28.43B
Revenue growth11.5%
Net incomeUSD 1.16T
Free cash flowUSD 1.30B
Gross margin26.4%

Valuation Snapshot

Bullrun's latest valuation model marks Medline Inc - Class A as 1.7% overvalued; latest market cap is USD 33.49B; P/E is 33.1.

About Medline Inc - Class A

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics.

Frequently asked questions

Is Medline Inc - Class A overvalued or undervalued?

Bullrun's valuation model currently marks Medline Inc - Class A as 1.7% overvalued.

What is Medline Inc - Class A's market cap?

Medline Inc - Class A's market capitalization is USD 33.49B.

What is Medline Inc - Class A's P/E ratio?

Medline Inc - Class A's price-to-earnings (P/E) ratio is 33.1.